C07C 233/28
Having the carbon atom of the carboxamide group bound to an acyclic
Official title: having the carbon atom of the carboxamide group bound to an acyclic carbon atom of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
C07C233/28 (Having the carbon atom of the carboxamide group bound to an acyclic) appears on 9 US grants and 11 published applications in this corpus.
Search patents in C07C- Granted patents
- 9
- Published applications
- 11
- Assignees
- 5
- Inventors
- 43
- Latest grant
- 19 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 2 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Immunoregulatory agents19 Mar 2024US 11,932,601 B2Flexus Biosciences, Inc.
- Immunoregulatory agents8 Feb 2022US 11,242,319 B2Flexus Biosciences, Inc.
- SHIP1 modulators and methods related thereto30 Apr 2019US 10,272,081 B2Aquinox Pharmaceuticals (Canada) Inc.
- SHIP1 modulators and methods related thereto10 Apr 2018US 9,937,167 B2Aquinox Pharmaceuticals (Canada) Inc.
- SHIP1 modulators and methods related thereto10 Jan 2017US 9,540,353 B2Aquinox Pharmaceuticals (Canada) Inc.
- Immunoregulatory agents1 Sep 2022US 2022/0274926 A1Flexus Biosciences, Inc.
- Immunoregulatory agents28 Mar 2019US 2019/0092729 A1Flexus Biosciences, Inc.
- Ship1 modulators and methods related thereto20 Dec 2018US 2018/0360828 A9Aquinox Pharmaceuticals (Canada) Inc.
- Ship1 modulators and methods related thereto14 Jun 2018US 2018/0161324 A1Aquinox Pharmaceuticals (Canada) Inc.
- Ship1 modulators and methods related thereto10 Aug 2017US 2017/0224682 A1Aquinox Pharmaceuticals (Canada) Inc.
Most cited
By later US patents
- Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers for physiological active agents132US 5,482,965 A1996
- VR1 vanilloid receptor antagonists with a iononic substructure5US 7,919,624 B2Pharmeste S.R.L. · 2011
- SHIP1 modulators and methods related thereto2US 9,540,353 B2Aquinox Pharmaceuticals (Canada) Inc. · 2017
- Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents1US 8,460,635 B2Albert Einstein College of Medicine of Yeshiva University · 2013